Synthesis method of modified cyclopeptide Triazole-Tiger17 derived from sea frog skin
Through the combination of hydrophobic carrier and click chemistry, the problems of high cost and high side reaction rates of synthesis of sea frog skin-derived modified cyclic peptide Triazole-Tiger17 were solved, and the efficient and low-consumption synthesis process was achieved, which improved the yield and Atomic economy.
Patent Information
- Application Number
- CN202411122288.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, the modified cyclic peptide Triazole-Tiger17 from the skin-derived sea frog has problems such as high cost, high solvent consumption and high side reaction rates. It is difficult for traditional methods to effectively avoid dimerization and polymerization side reactions, and the atomic economy is poor.
The method of combining hydrophobic carrier with click chemical method is used to form peptide bonds through amidation reaction, and cyclization is performed using click chemical method. The hydrophobic carrier and protecting group are then removed to avoid intermolecular coupling, and a homogeneous reaction system is realized, reducing Amino acid raw materials and solvent consumption.
It improves the synthesis yield, reduces raw material and solvent consumption, reduces production costs, avoids side reactions, and achieves efficient Triazole-Tiger17 synthesis.
Smart Images

Figure CN118909049A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a method for synthesizing a modified cyclic peptide Triazole-Tiger17 derived from sea frog skin. Background Art
[0002] The statements herein merely provide background information related to the present invention and do not necessarily constitute prior art.
[0003] Tiger17, with the sequence WCKPKPKPRCH-NH2, is a disulfide bond cyclic peptide derived from sea frog skin. It has been reported in a large number of literatures to promote the healing of skin injuries, enhance the proliferation and migration of keratinocytes and fibroblasts, and can be used in anti-aging, wrinkle removal, scar removal, freckle removal and skin lightening products. Triazole-Tiger17 is a modified cyclic peptide of Tiger17. Its anti-enzymatic ability and stability are greatly improved compared with natural amino acid peptides, its half-life is extended, it has good safety and tolerance, and few toxic and side effects. After safety investigation, it has been proved to meet the application requirements.
[0004]
[0005] Triazole-Tiger17 has three characteristics compared with common peptides:
[0006] 1. Triazole-Tiger17 is a cyclic peptide connected end to end. For this type of cyclic peptide, there are usually two traditional methods for its synthesis: one is to selectively activate and cyclize the protected linear precursor in a highly diluted solution. This method reacts slowly and is accompanied by side reactions such as a high proportion of dimers and polymers, resulting in low synthesis yields and the need to use a large amount of solvent; the other is to fix the linear peptide precursor on a peptide synthesis resin, which can effectively avoid dimerization and polymerization side reactions during the cyclization process. However, the limitation of this method is that the linear peptide precursor must contain specific amino acids, such as lysine, aspartic acid or asparagine, glutamic acid or glutamine, etc., and this method cannot be used for the synthesis of Triazole-Tiger17.
[0007] 2. Triazole-Tiger17 is a C-terminal amidated peptide. There are usually two methods for synthesizing such C-terminal amidated peptides: one is to use amino resin for solid phase peptide synthesis, and the other is to condense the carboxyl group with ammonia after cutting the peptide on the resin to form an amide bond. Both methods are solid phase synthesis methods, which are usually expensive, and the reaction is a heterogeneous reaction, requiring at least two equivalents of amino acid raw materials, and a large amount of solvent is required to wash the resin during the reaction. At the same time, the reaction progress and impurity generation cannot be effectively monitored by TLC method, and a large amount of raw materials and solvents are consumed, the atom economy is poor, and the production cost is high.
[0008] 3. Click chemistry to generate triazole-modified cyclic peptides. For this type of cyclic peptide, the traditional synthesis method is to use click chemistry in a highly diluted solution to selectively activate and cyclize the protected linear precursor, but there are still high proportions of side reactions such as dimers and polymers. Summary of the invention
[0009] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a method for synthesizing a modified cyclic peptide Triazole-Tiger17 derived from sea frog skin.
[0010] In order to achieve the above object, the present invention is implemented through the following technical solutions:
[0011] A method for synthesizing a modified cyclic peptide Triazole-Tiger17 derived from sea frog skin comprises the following steps:
[0012] After mixing a hydrophobic carrier, Fmoc-His(Trt)-OH, a catalyst, a solvent and a condensing agent in proportion, an amidation reaction is carried out to form a peptide bond, and then Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH are sequentially connected by the same method;
[0013] The prepared product H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG was cyclized by click chemistry;
[0014] The cyclization product is cleaved and the hydrophobic carrier and amino acid protecting group are removed to obtain Triazole-Tiger17.
[0015] In some embodiments, in the amidation reaction, the concentration of the hydrophobic carrier is 0.01-0.08 mmol / ml; the concentration of Fmoc-His(Trt)-OH is 0.03-0.1 mmol / ml.
[0016] Preferably, the amidation reaction temperature is 25-30° C., and the reaction time is 2-5 h.
[0017] In some embodiments, the hydrophobic carrier is a hydrophobic carrier that can form a C-terminal amidation modified polypeptide.
[0018] Preferably, the hydrophobic carrier is di[4-(docosyloxy)phenyl]methanamine.
[0019] In some embodiments, the solvent is dichloromethane, methyltetrahydrofuran, or acetonitrile.
[0020] In some embodiments, the condensing agent is dicyclohexylcarbodiimide (DCC), diisopropylcarbodiimide (DIC), or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI).
[0021] In some embodiments, after the amidation reaction between the hydrophobic carrier and Fmoc-His(Trt)-OH is completed, a step of adding 4-methylpiperidine to react is further included to remove the Fmoc protecting group.
[0022] In some embodiments, the click chemistry method for cyclization is as follows: acetonitrile, cuprous iodide, ascorbic acid and N,N-diisopropylethylamine are added to H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG, and the reaction is carried out at 25-30°C for 50-100 hours.
[0023] In some embodiments, the cleavage solution for cleaving the cyclization product is a mixture of TFA, Tis, H2O and EDT, and the volume ratio of TFA, Tis, H2O and EDT is 90-96:1-3:1-3:1.
[0024] Preferably, in the lysate, the volume ratio of TFA, Tis, H2O and EDT is 95:2:2:1.
[0025] Preferably, the cleavage reaction time is 2-4 hours.
[0026] Preferably, after the cleavage is completed, the cleavage solution is dried by spin drying, and the dried product is dispersed in methyl tert-butyl ether and stirred for a set time. The obtained precipitate is washed and dried with nitrogen to obtain a crude peptide product.
[0027] More preferably, the method further comprises the step of purifying the prepared crude peptide product by reverse phase high performance liquid chromatography using a C18 preparation column.
[0028] More preferably, mobile phase A is 0.1% trifluoroacetic acid / water solution, and mobile phase B is 0.1% trifluoroacetic acid / acetonitrile solution.
[0029] The beneficial effects achieved by one or more embodiments of the present invention are as follows:
[0030] The present invention is the first to use a hydrophobic carrier "molecular claw" combined with a "click chemistry" method to synthesize a C-terminal amidated triazole-modified cyclic peptide. This method has the advantage of "pseudo-dilution" in the cyclization synthesis of cyclic peptides on a resin, which is conducive to the intermolecular reaction.
[0031] The "click chemistry" cyclization reaction is a two-phase reaction. The peptide chain cyclization part is carried out in acetonitrile solution. Because its hydrophobic carrier is an insoluble part, it can effectively block intermolecular coupling, thereby effectively avoiding side reactions such as dimerization and polymerization during the cyclization process. The reaction solvents of this method are dichloromethane, methyltetrahydrofuran and acetonitrile, etc., thus overcoming the use of a large amount of harmful solvents such as dimethylformamide in solid-phase peptide synthesis.
[0032] Because solid phase synthesis is a heterogeneous reaction, it needs to consume at least twice the equivalent of amino acid raw materials, and a large amount of solvent is needed to wash the resin. This method uses a homogeneous reaction system during the amino acid coupling reaction, which avoids the problems of poor atomic economy and high production costs caused by excessive amino acid equivalents and large amounts of solvent washing, and reduces the consumption of raw materials and solvents. At the same time, compared with traditional methods, this method greatly improves the yield, the total yield is increased from ~35% to more than 66%, and the amino acid consumption is reduced by half. The synthesis method provided by the present invention has guiding significance for the synthesis of such modified polypeptides. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0034] Figure 1 It is a route map for synthesizing Triazole-Tiger17 by solid phase peptide synthesis in the comparative example of the present invention;
[0035] Figure 2 It is the mass spectrum of Triazole-Tiger17 synthesized in the embodiment of the present invention. DETAILED DESCRIPTION
[0036] It should be noted that the following detailed descriptions are illustrative and intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0037] The corresponding Chinese meanings of the English abbreviations of substances appearing in the claims and specification of the present invention are shown in Table 1 below.
[0038] Table 1
[0039]
[0040]
[0041] The present invention will be further described below in conjunction with the embodiments.
[0042] Example 1
[0043] The hydrophobic carrier method was used to synthesize Triazole-Tiger17. The specific steps are as follows:
[0044] In a 500 ml round-bottom flask, add 3.30 g (4.00 mmol, 1.0 eq) of di[4-(docosyloxy)phenyl]methylamine (TAG), 6.0 mmol (1.5 eq) of Fmoc-His(Trt)-OH, 8.0 mmol (2.0 eq) of DMAP and 100 ml of methyltetrahydrofuran, stir until dissolved, add 8.0 mmol (2.0 eq) of DIC dropwise, react at 25-30° C. for 4 hours, and the reaction is complete when detected by TLC. Wash three times with 100 ml of saturated ammonium chloride aqueous solution and saturated brine in sequence.
[0045] 2.00 g (2%) of 4-methylpiperidine was added, and the mixture was reacted at 25°C for 4 hours. The reaction was complete when detected by TLC. The mixture was washed three times with 100 ml of saturated ammonium chloride aqueous solution and saturated brine in sequence.
[0046] Next, Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH were connected in sequence. The connection method, reagent equivalent and post-treatment were consistent with those of Fmoc-His(Trt)-OH. The organic phase was concentrated to dryness to obtain H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG.
[0047] Add 300 mL of acetonitrile, 4.0 mmol of cuprous iodide, 12.0 mmol of ascorbic acid and 32.0 mmol of N,N-diisopropylethylamine into the round-bottom flask. The reaction system is a suspension. The reaction is carried out at 25-30°C for 72 hours. The reaction is complete when detected by TLC. Filter, wash the solid, and dry to obtain an off-white solid with a slight pink color.
[0048] The above-mentioned off-white slightly pink solid and 100 mL of lysis solution (TFA: Tis: H2O: EDT = 95: 2: 2: 1) were added to the round-bottom flask. The lysis was stirred for 3 hours. After the lysis was completed, the lysis solution was dried by spin drying, and the oily liquid after spin drying was released into 400 mL of methyl tert-butyl ether, stirred for half an hour, and a large amount of white precipitate was produced. Then, the filter cake was filtered and washed with methyl tert-butyl ether for several times, and dried by nitrogen.
[0049] The crude peptide was purified by reverse phase HPLC using a C18 preparative column (50*250mm, 10μm). Mobile phase A was 0.1% trifluoroacetic acid / water solution and mobile phase B was 0.1% trifluoroacetic acid / acetonitrile solution. The UV detection wavelength was 203nm. After concentration and freeze drying, 3.69g of pure product was obtained with a purity of 98.9% and a yield of 66.8%. The mass spectrum of Triazole-Tiger17 is shown in Figure 2 .
[0050] The hydrophobic carrier synthesis route of Triazole-Tiger17 is as follows:
[0051]
[0052] Example 2
[0053] The hydrophobic carrier method was used to synthesize Triazole-Tiger17. The specific steps are as follows:
[0054] Add 4.13 g (5.00 mmol, 1.0 eq) of di[4-(docosyloxy)phenyl]methylamine (TAG), 7.5 mmol (1.5 eq) of Fmoc-His(Trt)-OH, 10.0 mmol (2.0 eq) of DMAP and 130 ml of methyltetrahydrofuran into a 500 ml round-bottom flask, stir until dissolved, add 10.0 mmol (2.0 eq) of DIC dropwise, react at 25-30°C for 5 hours, and complete the reaction by TLC detection. Wash three times with 150 ml of saturated ammonium chloride aqueous solution and saturated brine in sequence.
[0055] 2.60 g of 4-methylpiperidine was added, and the mixture was reacted at 25°C for 4 hours. The reaction was complete when detected by TLC. The mixture was washed three times with 150 ml of saturated ammonium chloride aqueous solution and saturated brine.
[0056] Next, Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH were connected in sequence. The connection method, reagent equivalent and post-treatment were consistent with those of Fmoc-His(Trt)-OH. The organic phase was concentrated to dryness to obtain H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG.
[0057] Add 350 mL of acetonitrile, 5.0 mmol of cuprous iodide, 15.0 mmol of ascorbic acid and 40.0 mmol of N,N-diisopropylethylamine into the round-bottom flask. The reaction system is a suspension and reacts at 25-30°C for 66 hours. The reaction is complete when detected by TLC. Filter, wash the solid, and dry to obtain an off-white solid with a slight pink color.
[0058] The above-mentioned off-white slightly pink solid and 150 mL of lysis solution (TFA: Tis: H2O: EDT = 94: 2.5: 2.5: 1) were added to the round-bottom flask. The lysis was stirred for 3.5 hours. After the lysis was completed, the lysis solution was dried by spin drying, and the oily liquid after spin drying was released into 500 mL of methyl tert-butyl ether, stirred for half an hour, and a large amount of white precipitate was produced. Then, the filter cake was filtered and washed with methyl tert-butyl ether for several times, and dried by nitrogen.
[0059] The crude peptide was purified by reverse phase HPLC using a C18 preparative column (50*250 mm, 10 μm), with mobile phase A being 0.1% trifluoroacetic acid / water solution and mobile phase B being 0.1% trifluoroacetic acid / acetonitrile solution. The UV detection wavelength was 203 nm. After concentration and freeze drying, 4.64 g of pure product was obtained, with a purity of 98.7% and a yield of 67.3%.
[0060] Example 3
[0061] The hydrophobic carrier method was used to synthesize Triazole-Tiger17. The specific steps are as follows:
[0062] Add 6.60 g (8.00 mmol, 1.0 eq) of di[4-(docosyloxy)phenyl]methylamine (TAG), 12.0 mmol (1.5 eq) of Fmoc-His(Trt)-OH, 16.0 mmol (2.0 eq) of DMAP and 200 ml of methyltetrahydrofuran into a 500 ml round-bottom flask, stir until dissolved, add 16.0 mmol (2.0 eq) of DIC dropwise, react at 25-30°C for 6 hours, and complete the reaction by TLC detection. Wash three times with 100 ml of saturated ammonium chloride aqueous solution and saturated brine in sequence.
[0063] 4.00 g of 4-methylpiperidine was added, and the mixture was reacted at 25°C for 5 hours. The reaction was complete when detected by TLC. The mixture was washed three times with 200 ml of saturated ammonium chloride aqueous solution and saturated brine.
[0064] Next, Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH were connected in sequence. The connection method, reagent equivalent and post-treatment were consistent with those of Fmoc-His(Trt)-OH. The organic phase was concentrated to dryness to obtain H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG.
[0065] Add 600 mL of acetonitrile, 8.0 mmol of cuprous iodide, 24.0 mmol of ascorbic acid and 64.0 mmol of N,N-diisopropylethylamine into the round-bottom flask. The reaction system is a suspension. The reaction is carried out at 25-30°C for 90 hours. The reaction is complete when detected by TLC. Filter, wash the solid, and dry to obtain an off-white solid with a slight pink color.
[0066] The above-mentioned off-white slightly pink solid and 200 mL of lysis solution (TFA: Tis: H2O: EDT = 95: 2: 2: 1) were added to the round-bottom flask. Stir and lysis for 3 hours. After the lysis was completed, the lysis solution was dried by spin drying, and the oily liquid after spin drying was released into 1000 mL of methyl tert-butyl ether, stirred for half an hour, and a large amount of white precipitate was produced. Then, the filter cake was filtered and washed with methyl tert-butyl ether for several times, and dried by nitrogen.
[0067] The crude peptide was purified by reverse phase HPLC using a C18 preparative column (50*250 mm, 10 μm), with mobile phase A being 0.1% trifluoroacetic acid / water solution and mobile phase B being 0.1% trifluoroacetic acid / acetonitrile solution. The UV detection wavelength was 203 nm. After concentration and freeze drying, 7.55 g of pure product was obtained, with a purity of 99.3% and a yield of 68.4%.
[0068] Comparative Example 1
[0069] Triazole-Tiger17 was synthesized by solid phase peptide synthesis. The specific steps are as follows:
[0070] The linear peptide was synthesized by the conventional Fmoc-protected solid phase peptide synthesis method, and the cyclic peptide Triazole-Tiger17 was obtained by cyclization after cleavage. The resin selected was the amidable Rink Amide AM resin (loading amount was 0.45 mmol / g), and the resin was first activated, 8.9 g of Rink Amide AM resin was weighed into a reaction container, and the resin was washed three times with 140 mL of DCM, and 200 mL of DMF solution was added to swell for 30 min at room temperature under anhydrous conditions.
[0071] The resin was tested with ninhydrin. If the solution was colorless, the next step of reaction was carried out. 140 mL of 20% PIP / DMF was added twice to remove Fmoc, the first time for 5 minutes and the second time for 10 minutes. Then the ninhydrin test was performed. The solution was dark blue and the resin was yellow, indicating that Fmoc was completely removed.
[0072] Weigh 12.0mmol Fmoc-His(Trt)-OH, 12.0mmol HOBt, and 12.0mmol DIC, stir and dissolve, and add to the reaction system. Test with ninhydrin. If the solution is light yellow and the resin is colorless, the reaction is complete.
[0073] Then, according to the same condensing agent and equivalent weight, Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH were condensed in sequence to obtain Rink Amide AM-His(Trt)-DAP(N3)-Arg(Pbf)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-PRA-Trp(Boc)-NH2.
[0074] The resin was shrunk with 80 mL of methanol, washed three times, and then drained and dried.
[0075] The dried resin was placed in a round-bottom flask, and a lysis solution (TFA: Tis: H2O: EDT = 95: 2: 2: 1) was added at a ratio of 1: 10. The mixture was stirred and lysed for three hours. After the lysis was completed, the lysate was dried by spin drying, and the dried liquid was released into 300 mL of methyl tert-butyl ether and stirred for half an hour to produce a large amount of white precipitate, which was then filtered and the filter cake was washed with methyl tert-butyl ether for several times. Finally, the filter cake was freeze-dried and purified by chromatography to obtain the linear peptide H-Trp-PRA-Lys-Pro-Lys-Pro-Lys-Pro-Arg-DAP(N3)-His-NH2.
[0076] The linear peptide was dissolved in water to a peptide concentration of 1 g / L, 4.0 mmol copper (II) sulfate pentahydrate, 12.0 mmol sodium ascorbate and 32.0 mmol N,N-diisopropylethylamine were added, and stirred until the reaction was complete for mass spectrometry detection.
[0077] After the reaction is completed, freeze-drying is performed. The crude peptide is purified by reverse phase high performance liquid chromatography using a C18 preparative column (50*250mm, 10μm), with mobile phase A being 0.1% trifluoroacetic acid / water solution and mobile phase B being 0.1% trifluoroacetic acid / acetonitrile solution. The ultraviolet detection wavelength is 203nm. After concentration and freeze-drying, 1.92g of pure product is obtained, with a purity of 97.9% and a yield of 34.8%.
[0078] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for synthesizing a modified cyclic peptide Triazole-Tiger17 derived from sea frog skin, characterized in that: The steps include: After mixing a hydrophobic carrier, Fmoc-His(Trt)-OH, a catalyst, a solvent and a condensing agent in proportion, an amidation reaction is carried out to form a peptide bond, and then Fmoc-L-DAP(N3)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-PRA-OH and Fmoc-Trp(Boc)-OH are sequentially connected by the same method; The prepared product H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG was cyclized by click chemistry; The cyclization product is cleaved and the hydrophobic carrier and amino acid protecting group are removed to obtain Triazole-Tiger17.
2. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: In the amidation reaction, the concentration of the hydrophobic carrier is 0.01-0.08 mmol / ml; the concentration of Fmoc-His(Trt)-OH is 0.03-0.1 mmol / ml.
3. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 2, characterized in that: The temperature of the amidation reaction is 25-30°C, and the reaction time is 2-5h.
4. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: The hydrophobic carrier is a hydrophobic carrier that can form a C-terminal amidation modified polypeptide.
5. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 4, characterized in that: The hydrophobic carrier is di[4-(docosyloxy)phenyl]methanamine.
6. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: The solvent is dichloromethane, methyltetrahydrofuran or acetonitrile.
7. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: The condensing agent is dicyclohexylcarbodiimide (DCC), diisopropylcarbodiimide (DIC) or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI).
8. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: After the amidation reaction between the hydrophobic carrier and Fmoc-His(Trt)-OH is completed, the method further comprises the step of adding 4-methylpiperidine to react.
9. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: The click chemistry method for cyclization is as follows: acetonitrile, cuprous iodide, ascorbic acid and N,N-diisopropylethylamine are added to H-Trp(Boc)-PRA-Lys(Boc)-Pro-Lys(Boc)-Pro-Lys(Boc)-Pro-Arg(Pbf)-DAP(N3)-His(Trt)-TAG, and the mixture is reacted at 25-30° C. for 50-100 hours.
10. The method for synthesizing the modified cyclic peptide Triazole-Tiger17 derived from sea frog skin according to claim 1, characterized in that: The cleavage solution for cleaving the cyclized product is a mixture of TFA, Tis, H2O and EDT, and the volume ratio of TFA, Tis, H2O and EDT is 90-96:1-3:1-3:1; Preferably, in the lysate, the volume ratio of TFA, Tis, H2O and EDT is 95:2:2:1; Preferably, the cleavage reaction time is 2-4h; Preferably, after the cleavage is completed, the cleavage solution is dried by spin drying, and the dried product is dispersed in methyl tert-butyl ether and stirred for a set time. The obtained precipitate is washed and dried with nitrogen to obtain a crude peptide product; Preferably, the method further comprises the step of purifying the prepared crude peptide product by reverse phase high performance liquid chromatography using a C18 preparation column; Preferably, mobile phase A is 0.1% trifluoroacetic acid / water solution, and mobile phase B is 0.1% trifluoroacetic acid / acetonitrile solution.
